Seldin, D C <br/><br/>
High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution.  [electronic resource] 

 -  Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis  Jun 2011 
 - 127-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1744-2818 
<br/><br/><label>Standard No.: </label>10.3109/13506129.2011.574354047  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amyloidosis--drug therapy<br/>Combined Modality Therapy<br/>Dose-Response Relationship, Drug<br/>Humans<br/>Immunoglobulin Light Chains<br/>Stem Cell Transplantation<br/>Survival Rate<br/>Transplantation, Autologous